RPR121056 (Standard)

Overview

RPR121056 (Standard) is the analytical standard of RPR121056. This product is intended for research and analytical applications. RPR121056 ( APC ) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4 . Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer . Irinotecan also directly inhibits AChE[1].

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > Topoisomerase | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-100620R
• CAS No.: 181467-56-1
• Molecular Formula: C33H38N4O8
• Molecular Weight: 618.68
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source